Abstract
Germany, export-leading economy, is strongly investing in innovations. With the U.S., China, Japan, and India it belongs to the top five countries which are accounted for 59% of the public R&D worldwide. In Germany, innovations are invented in private sector and in the public universities. It is particularly the case in health care. The integrated infrastructure of university faculties and hospitals reflects this close connection.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 Springer Fachmedien Wiesbaden GmbH, part of Springer Nature
About this chapter
Cite this chapter
Kichko, K. (2019). Germany - a Follower or a Laggard. In: Personalized Medicine as Innovation. Gesundheitsmanagement und Gesundheitsökonomik. Springer Gabler, Wiesbaden. https://doi.org/10.1007/978-3-658-27843-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-658-27843-4_5
Published:
Publisher Name: Springer Gabler, Wiesbaden
Print ISBN: 978-3-658-27842-7
Online ISBN: 978-3-658-27843-4
eBook Packages: Economics and FinanceEconomics and Finance (R0)